Fibroblast‐growth‐factor‐23 in heart failure with preserved ejection fraction: relation to exercise capacity and outcomes

AIMS: This study aimed to assess plasma fibroblast growth factor 23 (FGF23) in patients with heart failure with preserved ejection fraction (HFpEF) and its relation to inflammation, renal function, clinical and imaging characteristics, exercise capacity, and prognosis. METHODS AND RESULTS: We perfor...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:ESC Heart Fail
Autori principali: Kanagala, Prathap, Arnold, Jayanth R., Khan, Jamal N., Singh, Anvesha, Gulsin, Gaurav S., Eltayeb, Mohamed, Gupta, Pankaj, Squire, Iain B., McCann, Gerry P., Ng, Leong L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2020
Soggetti:
Original Research Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7755022/
https://ncbi.nlm.nih.gov/pubmed/32935918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13020
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi